Alembic Pharmaceuticals Ltd
₹677.30
(3.33%)
Tue, 31 Mar 2026, 08:07 am
Health Technology
Pharmaceuticals: Major
24.5KAlembic Pharmaceuticals Return on Equity (ROE) History
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 7.01 | 11.88 | 22.73 | 30.20 | 15.73 | 29.16 | 25.12 | 17.12 | 12.14 | 16.31 | 27.97 | 28.51 | 31.36 | 31.31 |
| Price to book ratio | 0 | 0 | 2.31 | 3.90 | 7.92 | 9.66 | 7.09 | 6.18 | 4.67 | 3.67 | 3.09 | 3.78 | 2.79 | 2.22 | 4.01 | 3.52 |
| Price to sales ratio | 0 | 0 | 0.63 | 1.31 | 2.93 | 4.23 | 3.69 | 3.85 | 3.39 | 2.60 | 2.23 | 3.54 | 2.77 | 1.75 | 3.15 | 2.79 |
| Price to cash flow ratio | 0 | 0 | 8.44 | 7.72 | 23.67 | 50.60 | 11.98 | 36.22 | 36.02 | 13.40 | 29.60 | 13.43 | 28.85 | 14.44 | 25.49 | 1230 |
| Enterprise value | 0 | 0 | 12.19B | 21.34B | 54.36B | 87.81B | 109.85B | 116.86B | 109.83B | 109.24B | 117.81B | 189.9B | 152.2B | 103.88B | 196.96B | 194.32B |
| Enterprise value to EBITDA ratio | 0 | 0 | 6.15 | 9.58 | 16.85 | 24.43 | 11.51 | 20.43 | 19.66 | 13.95 | 9.97 | 13.65 | 17.73 | 15.65 | 23.21 | 21.49 |
| Debt to equity ratio | 0 | 1.11 | 0.90 | 0.37 | 0.16 | 0.30 | 0.07 | 0.05 | 0.32 | 0.41 | 0.56 | 0.12 | 0.14 | 0.16 | 0.11 | 0.24 |
| Return on equity % | 0 | 0 | 37.63 | 36.81 | 39.97 | 36.27 | 58.02 | 23.04 | 20.02 | 23.64 | 27.72 | 27.70 | 10.17 | 7.12 | 13.38 | 11.66 |
Alembic Pharmaceuticals Ltd Return on Equity
The Alembic Pharmaceuticals Ltd Return on Equity is a key financial metric used by investors to evaluate Alembic Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Alembic Pharmaceuticals Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Alembic Pharmaceuticals Ltd (NSE: APLLTD, BSE: 533573) is currently trading at ₹677.30, with a market capitalization of ₹133.08B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Alembic Pharmaceuticals Ltd Return on Equity is essential for fundamental analysis.
Alembic Pharmaceuticals Ltd Return on Equity Current Value
The current Alembic Pharmaceuticals Ltd Return on Equity stands at 11.66.
The Alembic Pharmaceuticals Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Alembic Pharmaceuticals Ltd Return on Equity Historical Trend
The Alembic Pharmaceuticals Ltd Return on Equity has shown the following historical trend:
- 2024: 11.66
- 2023: 13.38
- 2022: 7.12
- 2021: 10.17
- 2020: 27.70
The decline in Alembic Pharmaceuticals Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Alembic Pharmaceuticals Ltd Return on Equity Indicates for Investors
The Alembic Pharmaceuticals Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Alembic Pharmaceuticals Ltd Return on Equity Analysis Summary
The Alembic Pharmaceuticals Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alembic Pharmaceuticals Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Alembic Pharmaceuticals Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800